Komori
Revision to earnings forecast4360MANAC Chemical Partners Co.,LtdMaterials and Chemicals

FY2025 Financial Results Summary [Japanese GAAP] (Consolidated)

For the fiscal year ended March 2025, consolidated revenue fell 3.9% year on year to ¥9,304 million, operating and ordinary losses widened, and net income attributable to owners of the parent turned from a profit of ¥82 million to a loss of ¥895 million. In addition to weak performance in the flame retardants business, the company recorded an impairment loss of ¥516 million and has not disclosed an earnings forecast for the fiscal year ending March 2026 due to uncertainties including US tariff measures.

Worth reading
84Important
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Deterioration
Direction inferred from the company’s description.
Scale
-895
¥ million
Wording
Avoiding a definitive answer
How definitive the wording is.

Revised forecast

Fiscal year ending March 2025 · Full year
Reason for the revision

難燃剤事業における収益状況悪化。前期からの需要減少により販売数量・販売単価が低下したほか、生産設備等の回収可能性低下により減損損失516百万円を計上した。

Details and amount of extraordinary loss

Impairment loss ¥516 million / Total extraordinary loss ¥519 million / Loss on disposal of non-current assets ¥0 million / Loss on sale of investment securities ¥0 million / Loss on sale of golf club memberships ¥2 million

Previous-period resultsNet Sales 9,686百万円 / 営業損失(△) Operating loss of ¥105 million / 経常損失(△) △¥10 million / Profit attributable to owners of the parent ¥82 million / Net income per share 10円30銭
Dividend forecast revision2025年3月期期末配当は当初計画より2.5円減額して5.0円。2026年3月期は中間5.0円・期末5.0円の合計10.0円を予定。
Consolidated / non-consolidatedConsolidated
Revised forecast
ItemDetails
Fiscal Period CoveredFiscal year ending March 2025
Period CoveredFull year
Previous-period resultsNet Sales 9,686百万円 / 営業損失(△) Operating loss of ¥105 million / 経常損失(△) △¥10 million / Profit attributable to owners of the parent ¥82 million / Net income per share 10円30銭
Reason for the revision難燃剤事業における収益状況悪化。前期からの需要減少により販売数量・販売単価が低下したほか、生産設備等の回収可能性低下により減損損失516百万円を計上した。
Details and amount of extraordinary lossImpairment loss ¥516 million / Total extraordinary loss ¥519 million / Loss on disposal of non-current assets ¥0 million / Loss on sale of investment securities ¥0 million / Loss on sale of golf club memberships ¥2 million
Dividend forecast revision2025年3月期期末配当は当初計画より2.5円減額して5.0円。2026年3月期は中間5.0円・期末5.0円の合計10.0円を予定。
Consolidated / non-consolidatedConsolidated
Items this document does not state (6)
Net SalesOperating profitOrdinary incomeProfit attributable to owners of the parentNet income per sharePublication date of previous forecast

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

難燃剤事業で前期から需要減少が続き、販売数量・販売単価が低下したことで売上高・利益が減少した。加えて、生産設備等の回収可能性低下により減損損失516百万円を計上した。連結子会社の株式譲渡による売上減少も記載されている。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
FY2025 Financial Results Summary [Japanese GAAP] (Consolidated) | MANAC Chemical Partners Co.,Ltd (4360) timely disclosure | Komori